VIR (Vir Biotechnology) Insider Ownership: 3.62 % (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VIR Vir Biotechnology Inc VIR
52 GF Score
Price $9.80
GF Value $42.08
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Vir Biotechnology Insider Ownership?

Vir Biotechnology VIR +6.19% 52 Insider Ownership is 3.62 % as of Aug. 21, 2026. GuruFocus rates VIR with a GF Score™ of 52/100 and a GF Value™ of $42.08 (Possible Value Trap). The stock has 5 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vir Biotechnology's insider ownership is 3.62%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vir Biotechnology's Institutional Ownership is 83.42%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vir Biotechnology's Float Percentage Of Total Shares Outstanding is 98.76%.

Vir Biotechnology Insider Ownership Historical Data

* Premium members only.

The historical data trend for Vir Biotechnology's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vir Biotechnology Insider Ownership Chart

Vir Biotechnology Historical Data

The historical data trend for Vir Biotechnology can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 4.16 4.15 4.13 4.11 4.09 4.06 3.82 3.61 3.62 3.62
VIR
52GF Score
Vir Biotechnology Inc VIR
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vir Biotechnology Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 3.62 % mean?
Vir Biotechnology (VIR) has a Insider Ownership of 3.62 % as of Aug. 21, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Vir Biotechnology and its competitors.
Is Vir Biotechnology's Insider Ownership too high?
Vir Biotechnology's current Insider Ownership is 3.62 %. Overall, Vir Biotechnology has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vir Biotechnology's Insider Ownership compare to AVBP and XNCR?
Vir Biotechnology's Insider Ownership of 3.62 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Vir Biotechnology and its competitors. Vir Biotechnology's current Insider Ownership is 3.62 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vir Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Vir Biotechnology (VIR) is currently considered Possible Value Trap. The stock's GF Value™ is $42.08, compared to a current price of $9.80 — trading 76.7% below its estimated fair value. The current Insider Ownership is 3.62 %. Vir Biotechnology's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Vir Biotechnology (VIR), the current Insider Ownership is 3.62 % as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vir Biotechnology (VIR) Overvalued in 2026?

Based on GuruFocus' analysis, Vir Biotechnology stock appears to be undervalued. The current stock price of $9.80 is trading 76.7% below its estimated GF Value™ of $42.08. GuruFocus considers Vir Biotechnology to be Possible Value Trap.

Key valuation signals for VIR:

  • Insider Ownership: 3.62 %
  • GF Value™: $42.08 vs. price of $9.80 (76.7% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the VIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vir Biotechnology Business Description

Address 1800 Owens Street, Suite 900, San Francisco, CA, USA, 94158
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
52GF Score

Get the complete analysis for VIR

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.80
Price
$42.08
GF Value